| Antifibrinolytic |
Inhibiting the breakdown of fibrin, the blood component that forms the essential portion of a blood clot |
| Autosomal |
Relating to any chromosome that is not a sex chromosome
|
| Afibrinogenemia
|
The absence of fibrinogen from the blood |
| Coagulopathy
|
A disorder that prevents normal clotting of the blood |
| Dysfibrinogenemia
|
Malfunction of fibrinogen in the blood |
| Fibrinogen
|
Factor I, a protein in the blood that is converted to fibrin by the action of thrombin |
| Glycoprotein |
A protein compound that also contains carbohydrate |
| Hypofibrinogenemia |
A low or deficient level of fibrinogen in the blood |
| Platelet
|
A component of blood that contributes to coagulation |
| Prothrombin
|
Factor II, a protein in the blood that is converted to thrombin in the coagulation process |
| Thrombin |
An enzyme derived from prothrombin that converts fibrinogen to fibrin |
